Venture capital firms are investing in healthcare technologies, but startups can also tap into a $1.3 billion funding source from the U.S. government through the NIH’s SBIR and STTR programs. These programs support small businesses and R&D efforts with the potential for public benefit. Startups should understand the differences between SBIR and STTR, as well as the application process and funding limitations. Companies must be based in the U.S. and majority-owned by U.S. citizens to qualify for NIH funding. SEED, a new office at the NIH, provides entrepreneurial expertise to help startups navigate the process beyond just financial support.
Source link
5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow
